BRIEF published on 04/23/2026 at 15:15, 17 days 13 hours ago Newron Pharmaceuticals annonce les résultats de son assemblée générale annuelle 2026 Newron Pharmaceuticals Evenamide Membres Du Conseil D'administration Assemblée Générale Annuelle 2026 Xadago®
BRIEF published on 04/23/2026 at 15:15, 17 days 13 hours ago Newron Pharmaceuticals Announces AGM 2026 Results Board Members Newron Pharmaceuticals Evenamide AGM 2026 Xadago®
PRESS RELEASE published on 04/23/2026 at 15:10, 17 days 13 hours ago Newron announces AGM 2026 results Newron Pharmaceuticals S.p.A. announces successful AGM 2026 results including new Board members. Focus on developing therapies for nervous system diseases Board Members Newron Pharmaceuticals Thérapies AGM 2026 Nervous System Diseases
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Newron annonce ses résultats pour 2025 et ses perspectives pour 2026. Résultats Financiers Traitement De La Schizophrénie Perspectives Pour 2026 Brevet Accordé Essais Sur L'Evenamide
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Newron Announces 2025 Results and 2026 Outlook Financial Results Schizophrenia Treatment Patent Grant 2026 Outlook Evenamide Trials
PRESS RELEASE published on 03/24/2026 at 07:00, 1 month 17 days ago Newron presents 2025 financial results and provides 2026 outlook Newron Pharmaceuticals S.p.A. presents 2025 financial results and 2026 outlook, including progress on evenamide clinical trials and IP expansion Financial Results Clinical Trials Newron Pharmaceuticals 2026 Outlook IP Expansion
BRIEF published on 03/20/2026 at 07:05, 1 month 21 days ago Newron Pharmaceuticals to Present at SIRS 2026 Newron Pharmaceuticals Evenamide Treatment-resistant Schizophrenia Glutamate Modulation Schizophrenia Research
BRIEF published on 03/20/2026 at 07:05, 1 month 21 days ago Newron Pharmaceuticals présentera ses travaux au SIRS 2026 Newron Pharmaceuticals Evenamide Schizophrénie Résistante Au Traitement Modulation Du Glutamate Recherche Sur La Schizophrénie
PRESS RELEASE published on 03/20/2026 at 07:00, 1 month 21 days ago Newron to present at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS) Newron Pharmaceuticals S.p.A. to present at SIRS 2026 Congress on glutamatergic modulation in treatment-resistant schizophrenia Schizophrenia Newron Pharmaceuticals Congress Glutamatergic Modulation SIRS
BRIEF published on 03/19/2026 at 07:05, 1 month 22 days ago Newron Pharmaceuticals Extends Loan Repayment with EIB European Investment Bank Newron Pharmaceuticals Evenamide Finance Contract ENIGMA-TRS Phase III
Published on 05/09/2026 at 01:30, 2 days 3 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 4 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 12 hours 30 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 14 hours 35 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 16 hours 50 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 9 hours ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 7 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days 9 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 9 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 9 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 9 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 9 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
